Skip to main content

Table 2 Multivariate analysis of clinical and genetic factors

From: Prognostic relevance of acquired uniparental disomy in serous ovarian cancer

Variable

HR

95% CI

p

OS (all samples)

Ā Ā Ā 

Platinum status,

Ā Ā Ā 

Resistance vs sensitive

3.27

2.09-5.12

2.37Ɨ10āˆ’7

aUPD at

Ā Ā Ā 

whole-chromosome

1.82

1.15-2.88

0.0108

OS (sample set A)

Ā Ā Ā 

Platinum status,

Ā Ā Ā 

Resistance vs sensitive

5.14

2.81-9.4

1.01Ɨ10āˆ’7

aUPD at

Ā Ā Ā 

whole chromosome

2.17

1.29-3.66

0.0036

OS (sample set B)

Ā Ā Ā 

Platinum status,

Ā Ā Ā 

Resistance vs sensitive

2.48

1.12-5.47

0.0246

RFS (all samples)

Ā Ā Ā 

Platinum status,

Ā Ā Ā 

Resistance vs sensitive

4.16

3.07-5.64

2Ɨ10āˆ’16

RFS (sample set A)

Ā Ā Ā 

Platinum status

Ā Ā Ā 

Resistance vs sensitive

2.93

2.00-4.30

3.24Ɨ10āˆ’8

RFS (sample set B)

Ā Ā Ā 

Platinum status,

Ā Ā Ā 

Resistance vs sensitive

58.42

19.22-171.29

1.25Ɨ10āˆ’13

  1. Abbreviation: OS overall survival, RFS recurrence free survival, aUPD acquired uniparental disomy, HR hazard ratio, qā€‰<ā€‰0.05 was used to select features.